-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.
-
Summary
-
Scinai Immunotherapeutics Ltd. quarterly/annual General and Administrative Expense history and growth rate from Q1 2022 to Q2 2023.
- Scinai Immunotherapeutics Ltd. General and Administrative Expense for the quarter ending June 30, 2023 was $1.14M, a 11.5% decline year-over-year.
- Scinai Immunotherapeutics Ltd. annual General and Administrative Expense for 2022 was $1.5M, a 38.3% decline from 2021.
General and Administrative Expense, Quarterly (USD)
General and Administrative Expense, YoY Quarterly Growth (%)